Scientific Opinion on the substantiation of a health claim related to eicosapentanoic acid (EPA) and “reduces the AA/EPA ratio in blood. A high AA/EPA level is a risk factor in the development of attention difficulties in children with ADHD-like symptoms” pursuant to Article 14 of Regulation (EC) No 1924/2006

Scientific Opinion on the substantiation of a health claim related to eicosapentanoic acid (EPA) and “reduces the AA/EPA ratio in blood. A high AA/EPA level is a risk factor in the development of attention difficulties in children with ADHD-like symptoms” pursuant to Article 14 of Regulation (EC) No 1924/2006

Following an application from Minami Nutrition Health BVBA, submitted pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of Belgium, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of...

Full description

Bibliographic Details
Main Author: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Format: Article
Language:English
Published: Wiley 2013-04-01
Series:EFSA Journal
Subjects:
Eicosapentaenoic acid
EPA
arachidonic acid
AA/EPA ratio
attention deficit hyperactivity disorder
ADHD
health claims
Online Access:http://www.efsa.europa.eu/en/efsajournal/doc/3161.pdf

Internet

http://www.efsa.europa.eu/en/efsajournal/doc/3161.pdf

Similar Items